【摘要】 1999年韩国医疗保健开支为210亿美元,药品销售额在世界排名中居第10位。2001年销售额最高的10种药品是安氯地平、牛磺酸、白蛋白、奥利司他、紫杉醇、硝苯地平、拉米夫定、伊曲康唑、格列美脲、阿莫西林和克拉维酸。韩国医药公司的企业战略是削减向外购买产品许可的业务,兴起化学合成药物的生产,但韩国化学制药是否能适应市场对其产品的需求,目前前景尚不明了。更多还原

【Abstract】 In 1999 the expenditure on medical treatment and health protection in Korea was 21 billion US dollars, ranked NO. 10 place by sales volume in the world. The top 10 drugs by sales in 2001 in Korea were amlodipine, taurine, albumin, oxiracetam, paclitaxel, nifedipine, lamivudine, itraconazole, glimepiride, amoxicillin and clavulanate. Cutting down the operation to outsourcing product permission, raising the production of chemosynthetical drugs is the strategy of pharmaceutical enterprises in Korea, but it is unknown if chemical pharmacy in Korea accommodates the market demand for product.更多还原